v3.26.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Summary of Net Sales by Product Category Our management evaluates net sales disaggregated by product category within these two reportable segments as follows (in millions):
Three Months Ended March 31,
20262025
Specialty Nutrition Systems:
Enteral feeding$84.6 $74.5 
Neonate solutions39.4 26.6 
Total Specialty Nutrition Systems124.0 101.1 
Pain Management and Recovery:
Surgical pain and recovery21.8 24.5 
Radiofrequency ablation34.5 31.7 
Total Pain Management and Recovery56.3 56.2 
Corporate and Other1.9 10.2 
Total Net Sales$182.2 $167.5 
Summary of Liabilities for Estimated Returns, Rebates and Incentives
Accrued expenses consist of the following (in millions):
March 31, 2026December 31, 2025
Accrued rebates and customer incentives$11.0 $13.1 
Accrued salaries and wages21.7 37.0 
Accrued taxes and other6.6 16.9 
Other(a)
18.3 24.3 
Total Accrued Expenses$57.6 $91.3 
__________________________________________________
(a)Other includes $7.5 million of contingent consideration associated with the acquisition of Nexus. See Note 3, “Business Acquisition” for further information.
Liabilities for estimated returns, rebates and incentives are presented in the table below (in millions):
March 31, 2026December 31, 2025
Accrued rebates$1.0 $3.3 
Accrued customer incentives10.0 9.8 
Accrued rebates and customer incentives11.0 13.1 
Accrued sales returns(a)
0.1 0.1 
Total estimated liabilities$11.1 $13.2 
__________________________________________________
(a)Accrued sales returns are included in “Other” in the accrued expenses table in Note 5, “Supplemental Balance Sheet Information”.